The lower overall survival in patients with PC was directly correlated to positive OPN expression as demonstrated by Caruzo et al. [37], which investigated the expression of several biomarkers, including OPN, in PC tissue samples from 161 patients and their correlation with disease progression and overall survival, showing that higher OPN expression in PC was linked to poor patient prognosis. This evidence concerns the gene SPP1 and pachyonychia congenita.